NCT01992211View on ClinicalTrials.gov

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 15, 2016

Primary Completion Date

April 28, 2017

Study Completion Date

July 10, 2017

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Participants will be co-administered a single oral dose of Rosuvastatin 10mg and Metformin SR 1000mg under Fed condition.

DRUG

Metformin

Participants will be co-administered a single oral dose of Rosuvastatin 10mg and Metformin SR 1000mg under Fed condition.

DRUG

BCWP_C003

Participant will be administered a single oral dose of BCWP\_C003 under Fasting condition or Fed condition according to sequence.

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

BC World Pharm Co. Ltd.

INDUSTRY

NCT01992211 - Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin | Biotech Hunter | Biotech Hunter